In this issue:
Lifestyle and genetic risks for incident psoriasis
Alcohol consumption and smoking in relation to psoriasis
Indirect comparisons of systemic biologics for psoriasis
Patient characteristics and treatment patterns in paediatric psoriasis
Adalimumab for paediatric generalised pustular psoriasis
Identifying patients with deteriorating generalised pustular psoriasis
Bimekizumab vs other biologics for plaque psoriasis
Mirikizumab in psoriasis
Estimation of body surface area error
PASI thresholds as proxies for systemic inflammation
Methotrexate in paediatric patients with plaque psoriasis
Please login below to download this issue (PDF)